Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv
Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App
Budget Express 2026

co-presented by

  • LIC
  • JIO BlackRock

ASSOCIATE SPONSORS

  • Sunteck
  • SBI
  • Emirates
  • Dezerv

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01031 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Jan 30, 16:01
1215.70 7.25 (0.60%)
Volume
AVERAGE VOLUME
5-Day
362,381
10-Day
313,456
30-Day
134,545
21,416
  • Prev. Close

    1208.45

  • Open Price

    1198.60

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jan 30, 15:59
1218.10 9.20 (0.76%)
Volume
AVERAGE VOLUME
5-Day
3,175,903
10-Day
2,729,566
30-Day
1,598,327
1,672,460
  • Prev. Close

    1208.90

  • Open Price

    1200.00

  • Bid Price (Qty.)

    1218.10 (63)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Dr Reddys Laboratories (in Rs. Cr.) Mar 05 Mar 04  
  12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 1,625.56 1,740.20  
Less: Excise/Sevice Tax/Other Levies 76.80 78.98  
Revenue From Operations [Net] 1,548.76 1,661.22  
Total Operating Revenues 1,548.76 1,661.22  
Other Income -8.41 32.52  
Total Revenue 1,540.35 1,693.73  
EXPENSES  
Cost Of Materials Consumed 451.17 508.87  
Purchase Of Stock-In Trade 166.08 123.33  
Operating And Direct Expenses 47.43 42.42  
Changes In Inventories Of FG,WIP And Stock-In Trade -29.62 -9.66  
Employee Benefit Expenses 178.66 161.39  
Finance Costs 3.76 0.59  
Depreciation And Amortisation Expenses 92.46 71.72  
Other Expenses 580.81 491.73  
Total Expenses 1,495.99 1,390.39  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 44.36 303.34  
Exceptional Items 0.00 0.00  
Profit/Loss Before Tax 44.36 303.34  
Tax Expenses-Continued Operations  
Current Tax 0.00 20.24  
Less: MAT Credit Entitlement 0.00 0.00  
Deferred Tax -21.10 -0.09  
Tax For Earlier Years 0.00 0.00  
Total Tax Expenses -21.10 20.15  
Profit/Loss After Tax And Before ExtraOrdinary Items 65.46 283.20  
Profit/Loss From Continuing Operations 65.46 283.20  
Profit/Loss For The Period 65.46 283.20  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 8.55 37.01  
Diluted EPS (Rs.) 8.55 37.01  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 184.70 165.02  
Indigenous Raw Materials 153.17 238.46  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 9.63 9.24  
Indigenous Stores And Spares 60.46 54.91  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 38.26 38.26  
Tax On Dividend 5.37 4.90  
Equity Dividend Rate (%) 100.00 100.00  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347